{"retracted":false,"update":{"timestamp":1463011200000,"doi":"10.1007/s00125-016-3987-3","type":"correction"},"doi":"10.1007/s00125-016-3956-x","journal":"Diabetologia","publisher":"Springer Nature","title":"Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?"}
